NewsHKSubscribe
Markets市場

Abivax Shares Surge 34% on New Data for Lead Bowel Disease Drug

Shares of French biotech company Abivax surged 34% on Tuesday after the company released fresh data on its experimental lead medicine targeting bowel disease. The single-session move placed the Paris-listed name among the sharper…

By Marcus Cole·July 5, 2026·二〇二六年七月五日·2 min read

Source · 來源

cnbc.com

Share · 分享
Xinfw
← Back to the News DeskFiled · Markets

Related Dispatches

相關報導
News Desk →
  1. 01Markets市場

    The four stocks Wall Street fears most are also its best performers

    Four stocks that Wall Street has ranked as its most hated and feared are also, by the market's own accounting, delivering…

    August 16, 2026 · 2 min

  2. 02Markets市場

    3G Capital Partners exits Amazon and opens Intel position in second-quarter filings

    Filing-season disclosures carry a rotation signal before analyst coverage lands. In its second-quarter regulatory filing, 3G…

    August 16, 2026 · 2 min

  3. 03Markets市場

    Army awards Boeing $636 million contract for Apache helicopter support

    U.S. military procurement in the rotary-wing segment has been a consistent source of contract flow, and the latest award adds…

    August 16, 2026 · 2 min

Elsewhere on the Desk

All Dispatches →
Regulatory

Axe Compute signs more than $3 billion in 2026 contracts as Q2 revenue reaches $3.2 million

August 17, 2026 · 2 min

Crypto加密

Chainalysis sues US government over $95M ICE contract awarded to TRM Labs

August 17, 2026 · 2 min

Regulatory

Carvana swaps distress-era debt for $1.66 billion term loan B, targeting 2033 maturity

August 17, 2026 · 2 min

Macro

Philippine central bank flags stronger second-round inflation effects

August 17, 2026 · 2 min